An article in The Verge reports that ongoing research has demonstrated many shared genetic pathways for schizophrenia, bipolar disorder, and depression.  Such shared genetic foundations can result in similarities in brain signaling, genome functioning, and patterns of immunity.  These findings may have important implications for new directions in the development of medications to treat these disorders.  To read this article in its entirety, click here.